About

Dr. Yuchen Su is a pioneering surgeon whose work bridges two demanding fields: urologic oncology and thoracic surgery. His research focuses on refining robot-assisted surgical techniques to improve outcomes for patients with prostate and esophageal cancers. In urology, Dr. Su has made significant contributions to understanding positive surgical margins in high-risk prostate cancer, with his 2014 study on pT3 disease (18 citations) being one of the largest series to analyze margin trends after robot-assisted radical prostatectomy (RARP). He also investigated how prior transurethral surgery impacts oncologic and continence outcomes post-RARP (24 citations), providing critical guidance for surgical planning. In thoracic surgery, Dr. Su leads efforts to advance robot-assisted esophagectomy (RAE) for esophageal squamous cell carcinoma, reporting on a substantial series of 249 patients (19 citations). His annual reports from Shanghai Chest Hospital (2016, 2017) offer real-world data on esophageal cancer survival, underscoring his commitment to evidence-based practice. With over 70 combined citations, Dr. Su’s work directly shapes surgical decision-making and patient care in two complex oncologic specialties.

Research Focus

Key Achievements

4
H-Index
6
Papers
74
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Does previous transurethral prostate surgery affect oncologic and continence outcomes after RARP?
24 citations · 2015
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: University of Southern California, Shanghai Chest Hospital, University of Pennsylvania, Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago